Related Experiment Videos
Renal cell carcinoma
1University of North Carolina at Chapel Hill, Division of Hematology/Oncology and the Lineberger Comprehensive Cancer Center, Chapel Hill 27599-7305, USA. pgodley@med.unc.edu
Current Opinion in Oncology
|June 7, 2000
Summary
Renal cell carcinoma incidence is rising, linked to factors like hypertension and diet. Early detection and treatments like partial nephrectomy and immunotherapy offer improved survival outcomes.
Area of Science:
- Oncology
- Urology
Background:
- Rising incidence of renal cell carcinoma (RCC) with unclear causes beyond increased imaging.
- Identified risk factors include hypertension, smoking, obesity, and dietary patterns.
- Carotene intake shows an inverse association with RCC risk, while red meat intake correlates with increased risk.
Purpose of the Study:
- To review current understanding of renal cell carcinoma incidence, risk factors, and treatment modalities.
- To highlight prognostic indicators for patient survival.
- To discuss emerging therapeutic strategies and their efficacy.
Main Methods:
- Literature review of epidemiological data and clinical studies on renal cell carcinoma.
- Analysis of risk factors, including lifestyle and genetic predispositions.
- Evaluation of treatment outcomes for localized disease, metastatic disease, and systemic therapy.
Main Results:
- Partial nephrectomy shows comparable effectiveness to radical nephrectomy for localized RCC.
- Radiosurgery is a viable alternative to surgical resection for brain metastases.
- Immunotherapy demonstrates response rates of 5-20% in systemic treatment.
Conclusions:
- Survival in renal cell carcinoma is influenced by pathologic stage, grade, vascular invasion, and specific genetic alterations.
- Prognosis is worsened by genetic factors such as deletion (8p)/-8, +12, and +20.
- Continued research into risk factors and treatment optimization is crucial for improving patient outcomes.